FDA OKs Generic Medrol

Article

Methylprednisolone Tablets had annual sales of approximately $114.3 million in the United States.

Officials with Lupin announced this week that they has received FDA approval for to market a generic version of Pharmacia and Upjohn Company's Medrol tablets

The methylprednisolone tablets will come in 2 mg, 4 mg, 8 mg, 16 mg and 32 mg dosages. They areindicated to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, and neoplastic disorders, edematous states, gastrointestinal diseases, acute exacerbations of multiple sclerosis, tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy, Trichinosis with neurologic or myocardial involvement.

Methylprednisolone Tablets had annual sales of approximately $114.3 million in the United States.

Related Videos
Female Pharmacist Holding Tablet PC - Image credit: Tyler Olson | stock.adobe.com
African American male pharmacist using digital tablet during inventory in pharmacy - Image credit: sofiko14 | stock.adobe.com
Young woman using smart phone,Social media concept. - Image credit: Urupong | stock.adobe.com
selling mental health medication to man at pharmacy | Image Credit: Syda Productions - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Image credit: rawpixel.com | stock.adobe.com
Medical team -- Image credit: Flamingo Images | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.